* We recommend a score >= 0.08 for meaningful Gene-Disease associations

GeneID Gene_Symbol DisGeNet_diseaseID Disease_name DisGeNet score DisGeNet_sourceDB
5591PRKDCC4014833IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES0.4ORPHANET;UNIPROT
5591PRKDCC0085110Severe Combined Immunodeficiency0.202472541057918BEFREE;HPO
5591PRKDCC4277682Chemical and Drug Induced Liver Injury0.2CTD_human
5591PRKDCC0001364Massive Hepatic Necrosis0.2CTD_human
5591PRKDCC4020899Autosomal recessive predisposition0.2HPO
5591PRKDCC3163798Recurrent lower respiratory tract infection0.2HPO
5591PRKDCC2937365Recurrent aphthous ulcer0.2HPO
5591PRKDCC1848924Infantile onset0.2HPO
5591PRKDCC0424688Small head0.2HPO
5591PRKDCC0149725Lower respiratory tract infection0.2HPO
5591PRKDCC0038363Aphthous Stomatitis0.2HPO
5591PRKDCC0033578Prostatic Neoplasms0.2CTD_human
5591PRKDCC0024115Lung diseases0.2CTD_human
5591PRKDCC0019151Hepatic Encephalopathy0.2CTD_human
5591PRKDCC0010606Adenoid Cystic Carcinoma0.2CTD_human
5591PRKDCC0007137Squamous cell carcinoma0.2CTD_human
5591PRKDCC1832322Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Negative, NK Cell-Positive0.08MGD
5591PRKDCC0006142Malignant neoplasm of breast0.0110017480142175BEFREE;GAD
5591PRKDCC1458155Mammary Neoplasms0.00819873739444126LHGDN
5591PRKDCC0005684Malignant neoplasm of urinary bladder0.0074958123540771BEFREE;GAD
5591PRKDCC0004135Ataxia Telangiectasia0.0062900052822668BEFREE;LHGDN
5591PRKDCC0376358Malignant neoplasm of prostate0.0059129641834284BEFREE;GAD
5591PRKDCC0153633Malignant neoplasm of brain0.004814057046576GAD
5591PRKDCC0017636Glioblastoma0.00410654638587925BEFREE;LHGDN
5591PRKDCC0017638Glioma0.0037806624443535BEFREE;GAD
5591PRKDCC0027627Neoplasm Metastasis0.00328236603323995BEFREE;LHGDN
5591PRKDCC0005695Bladder Neoplasm0.00300763924902685BEFREE;LHGDN
5591PRKDCC0004114Astrocytoma0.00273291246481375LHGDN
5591PRKDCC0023418leukemia0.00273291246481375LHGDN
5591PRKDCC0038356Stomach Neoplasms0.00273291246481375LHGDN
5591PRKDCC3714514Infection0.00273291246481375LHGDN
5591PRKDCC0024121Lung Neoplasms0.00273291246481375LHGDN
5591PRKDCC0006118Brain Neoplasms0.0026817553075011BEFREE;GAD
5591PRKDCC0278996Cancer of Head and Neck0.002407028523288GAD
5591PRKDCC0040336Tobacco Use Disorder0.002407028523288GAD
5591PRKDCC0026769Multiple Sclerosis0.002407028523288GAD
5591PRKDCC0040136Thyroid Neoplasm0.002407028523288GAD
5591PRKDCC0242379Malignant neoplasm of lung0.002407028523288GAD
5591PRKDCC0024305Lymphoma, Non-Hodgkin0.002407028523288GAD
5591PRKDCC0023434Chronic Lymphocytic Leukemia0.002407028523288GAD
5591PRKDCC0007133Carcinoma, Papillary0.002407028523288GAD
5591PRKDCC2239176Liver carcinoma0.0010989071368524BEFREE
5591PRKDCC0678222Breast Carcinoma0.0010989071368524BEFREE
5591PRKDCC0600139Prostate carcinoma0.0010989071368524BEFREE
5591PRKDCC0007131Non-Small Cell Lung Carcinoma0.0008241803526393BEFREE
5591PRKDCC0178874Tumor Progression0.0005494535684262BEFREE
5591PRKDCC0699790Colon Carcinoma0.0005494535684262BEFREE
5591PRKDCC1512409Hepatocarcinogenesis0.0005494535684262BEFREE
5591PRKDCC1168401Squamous cell carcinoma of the head and neck0.0005494535684262BEFREE
5591PRKDCC0596263Carcinogenesis0.0005494535684262BEFREE
5591PRKDCC1527249Colorectal Cancer0.0005494535684262BEFREE
5591PRKDCC0009402Colorectal Carcinoma0.0005494535684262BEFREE
5591PRKDCC0025202melanoma0.0005494535684262BEFREE
5591PRKDCC0004364Autoimmune Diseases0.0005494535684262BEFREE
5591PRKDCC1865370Severe combined immunodeficiency with sensitivity to ionizing radiation0.0002747267842131BEFREE
5591PRKDCC0558355Tonsillar Carcinoma0.0002747267842131BEFREE
5591PRKDCC0585442Osteosarcoma of bone0.0002747267842131BEFREE
5591PRKDCC4048328cervical cancer0.0002747267842131BEFREE
5591PRKDCC0004096Asthma0.0002747267842131BEFREE
5591PRKDCC3828416Radiation Damage0.0002747267842131BEFREE
5591PRKDCC0004134Ataxia0.0002747267842131BEFREE
5591PRKDCC0684249Carcinoma of lung0.0002747267842131BEFREE
5591PRKDCC1883486Uterine Corpus Cancer0.0002747267842131BEFREE
5591PRKDCC1261473Sarcoma0.0002747267842131BEFREE
5591PRKDCC0699791Stomach Carcinoma0.0002747267842131BEFREE
5591PRKDCC0699885Carcinoma of bladder0.0002747267842131BEFREE
5591PRKDCC0700095Central neuroblastoma0.0002747267842131BEFREE
5591PRKDCC1621958Glioblastoma Multiforme0.0002747267842131BEFREE
5591PRKDCC0948750Salivary gland carcinoma0.0002747267842131BEFREE
5591PRKDCC0002726Amyloidosis0.0002747267842131BEFREE
5591PRKDCC0029463Osteosarcoma0.0002747267842131BEFREE
5591PRKDCC0007758Cerebellar Ataxia0.0002747267842131BEFREE
5591PRKDCC0007847Malignant tumor of cervix0.0002747267842131BEFREE
5591PRKDCC0015625Fanconi Anemia0.0002747267842131BEFREE
5591PRKDCC0007103Malignant neoplasm of endometrium0.0002747267842131BEFREE
5591PRKDCC0021051Immunologic Deficiency Syndromes0.0002747267842131BEFREE
5591PRKDCC0023473Myeloid Leukemia, Chronic0.0002747267842131BEFREE
5591PRKDCC0023531Leukoplakia0.0002747267842131BEFREE
5591PRKDCC0007102Malignant tumor of colon0.0002747267842131BEFREE
5591PRKDCC0024141Lupus Erythematosus, Systemic0.0002747267842131BEFREE
5591PRKDCC0024299Lymphoma0.0002747267842131BEFREE
5591PRKDCC0024623Malignant neoplasm of stomach0.0002747267842131BEFREE
5591PRKDCC0025149Medulloblastoma0.0002747267842131BEFREE
5591PRKDCC0026764Multiple Myeloma0.0002747267842131BEFREE
5591PRKDCC0027819Neuroblastoma0.0002747267842131BEFREE
5591PRKDCC0555198Malignant Glioma0.0002747267842131BEFREE
5591PRKDCC0032580Adenomatous Polyposis Coli0.0002747267842131BEFREE
5591PRKDCC0043346Xeroderma Pigmentosum0.0002747267842131BEFREE
5591PRKDCC0005699Blast Phase0.0002747267842131BEFREE
5591PRKDCC0085281Addictive Behavior0.0002747267842131BEFREE
5591PRKDCC0149925Small cell carcinoma of lung0.0002747267842131BEFREE
5591PRKDCC0153690Secondary malignant neoplasm of bone0.0002747267842131BEFREE
5591PRKDCC0206656Rhabdomyosarcoma, Embryonal0.0002747267842131BEFREE
5591PRKDCC0270814Spastic syndrome0.0002747267842131BEFREE
5591PRKDCC0275524Coinfection0.0002747267842131BEFREE
5591PRKDCC0302592Cervix carcinoma0.0002747267842131BEFREE
5591PRKDCC0338656Impaired cognition0.0002747267842131BEFREE
5591PRKDCC0346429Multiple malignancy0.0002747267842131BEFREE
5591PRKDCC0398686Primary immune deficiency disorder0.0002747267842131BEFREE
5591PRKDCC0476089Endometrial Carcinoma0.0002747267842131BEFREE